 | | PRD_000151 | | Name: | GRAMICIDIN B | | Formula: | C97 H139 N19 O17 | | Description: | GRAMICIDIN B IS A HEXADECAMERIC HELICAL PEPTIDE
WITH ALTERNATING D,L CHARACTERISTICS.
THE N-TERM IS FORMYLATED (RESIDUE 0).
THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000152 | | Name: | GRAMICIDIN D | | Formula: | C99 H140 N20 O17 | | Description: | GRAMICIDIN D IS A HEXADECAMERIC HELICAL PEPTIDE
WITH ALTERNATING D,L CHARACTERISTICS.
THE N-TERM IS FORMYLATED (RESIDUE 1).
THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000153 | | Name: | GRAMICIDIN C | | Formula: | C99 H140 N20 O17 | | Description: | GRAMICIDIN C IS A HEXADECAMERIC HELICAL PEPTIDE
WITH ALTERNATING D,L CHARACTERISTICS.
THE N-TERM IS FORMYLATED (RESIDUE 0).
THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000154 | | Name: | MINI-GRAMICIDIN A DIMER | | Formula: | C168 H226 N32 O26 | | Description: | THE N-TERMINI OF THE TWO IDENTICAL PEPTIDES, EACH
A TRUNCATED GRAMICIDIN A WERE LINKED BY A SUCCINIC
ACID IN A HEAD-TO-HEAD MANNER. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000155 | | Name: | MINI-GRAMICIDIN A - GRAMICIDIN A DIMER | | Formula: | C180 H244 N34 O30 | | Description: | THE N-TERMINI OF THE TWO PEPTIDES, EACH A
TRUNCATED GRAMICIDIN A, WERE LINKED BY A SUCCINIC
ACID IN A HEAD-TO-HEAD MANNER. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000156 | | Name: | Cephaibol A | | Formula: | C82 H127 N17 O20 | | Description: | CEPHAIBOL A IS A HEXADECAMERIC HELICAL PEPTIDE.
THE N-TERM IS ACETYLATED (RESIDUE 0) | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000937 | | Name: | peptide inhibitor | | Formula: | C33 H50 N4 O9 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000157 | | Name: | Cephaibol B | | Formula: | C83 H129 N17 O20 | | Description: | CEPHAIBOL A IS A HEXADECAMERIC HELICAL PEPTIDE.
THE N-TERM IS ACETYLATED (RESIDUE 0) | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000158 | | Name: | Cephaibol C | | Formula: | C82 H127 N17 O20 | | Description: | CEPHAIBOL C IS A HEXADECAMERIC HELICAL PEPTIDE.
THE N-TERM IS ACETYLATED (RESIDUE 0) | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000159 | | Name: | Zervamicin IIB | | Formula: | C90 H139 N19 O22 | | Description: | ZERVAMICIN IS A HEXADECAMERIC HELICAL PEPTIDE.
THE N-TERM IS ACETYLATED (RESIDUE 0) | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000160 | | Name: | TRICHOTOXIN A50E | | Formula: | C78 H136 N20 O21 | | Description: | TRICHOTOXIN_A50E IS AN OCTADECAMERIC HELICAL PEPTIDE.
THE N-TERM IS ACETYLATED (RESIDUE 0) | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000161 | | Name: | Antiamoebin 1 | | Formula: | C82 H127 N17 O20 | | Description: | ANTIAMOEBIN I IS A HEXADECAMERIC HELICAL PEPTIDE.
THE N-TERM IS ACETYLATED (RESIDUE 0) | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000162 | | Name: | Chrysospermin-C | | Formula: | C91 H142 N22 O23 | | Description: | CHRYSOSPERMIN C IS A NONADECAMERIC HELICAL PEPTIDE.
THE N-TERM IS ACETYLATED (RESIDUE 0) | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000944 | | Name: | N-{(2S)-1-[(2-chlorobenzyl)amino]-1-oxo-4-phenylbutan-2-yl}-N~2~-[3-(2-methylphenyl)propanoyl]-L-threoninamide | | Formula: | C31 H36 Cl N3 O4 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000163 | | Name: | Alamethicin | | Formula: | C92 H150 N22 O25 | | Description: | ALAMETHICIN F30 IS AN EICOSAMERIC HELICAL PEPTIDE.
THE N-TERM IS ACETYLATED (RESIDUE 0) | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000946 | | Name: | N~2~-acetyl-N-[(2S,3R)-4-{(1,3-benzothiazol-6-ylsulfonyl)[(2S)-2-methylbutyl]amino}-3-hydroxy-1-phenylbutan-2-yl]-L-isoleucinamide | | Formula: | C30 H42 N4 O5 S2 | | Description: | SYNTHETIC HIV-1 PROTEASE INHIBITOR | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000180 | | Name: | Antipain | | Formula: | C27 H46 N10 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000947 | | Name: | N-{(2S,3R)-4-[(1,3-benzothiazol-6-ylsulfonyl)(cyclohexylmethyl)amino]-3-hydroxy-1-phenylbutan-2-yl}-3-hydroxybenzamide | | Formula: | C31 H35 N3 O5 S2 | | Description: | SYNTHETIC HIV-1 PROTEASE INHIBITOR | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000183 | | Name: | Microcin C7 | | Formula: | C28 H49 N12 O10 S | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000948 | | Name: | N-{(2S,3R)-4-[(1,3-benzothiazol-6-ylsulfonyl)(3-phenylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl}-3-hydroxybenzamide | | Formula: | C33 H33 N3 O5 S2 | | Description: | SYNTHETIC HIV-1 PROTEASE INHIBITOR | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000184 | | Name: | Microcin J25 | | Formula: | C101 H140 N23 O27 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000949 | | Name: | 3-hydroxy-N-[(2S,3R)-3-hydroxy-4-([(2S)-2-methylbutyl]{[5-(1,2-oxazol-5-yl)thiophen-2-yl]sulfonyl}amino)-1-phenylbutan-2-yl]benzamide | | Formula: | C29 H33 N3 O6 S2 | | Description: | SYNTHETIC HIV-1 PROTEASE INHIBITOR | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000950 | | Name: | N~2~-acetyl-N-[(2S,3R)-4-{(1,3-benzothiazol-6-ylsulfonyl)[(2S)-2-methylbutyl]amino}-3-hydroxy-1-phenylbutan-2-yl]-L-leucinamide | | Formula: | C30 H42 N4 O5 S2 | | Description: | SYNTHETIC HIV-1 PROTEASE INHIBITOR | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000186 | | Name: | EFRAPEPTIN C | | Formula: | C80 H138 N18 O16 | | Description: | EFRAPEPTIN C IS A LINEAR PEPTIDE, WITH ACETYLATED
(ACE) PIPECOLIC ACID (YCP) AT THE N-TERMINUS AND
A MODIFIED LEUCINE AT THE C-TERM (TLX) | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000951 | | Name: | 3-hydroxy-N-[(2S,3R)-3-hydroxy-4-{[(4-methoxyphenyl)sulfonyl](2-methylpropyl)amino}-1-phenylbutan-2-yl]benzamide | | Formula: | C28 H34 N2 O6 S | | Description: | SYNTHETIC HIV-1 PROTEASE INHIBITOR | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
